The effects on clinical characteristics, potential factors and outcomes in SAPHO patients during the COVID-19 epidemic
Open Access
- 16 July 2025
- journal article
- medicine
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1580989
Abstract
Objectives: The coronavirus disease (COVID-19) pandemic has potentially impacted the care of patients with rheumatic diseases, including Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) syndrome. We investigates the effects on clinical characteristics, potential factors, and outcomes in SAPHO patients during the COVID-19 pandemic.Methods: SAPHO patients were recruited for this cross-sectional study from Fangshan Hospital of Beijing University of Chinese Medicine. In total, 375 patients (mean age, 47.5 years, 72.53% females) were asked about demographic data, disease status, current treatments, and clinical manifestations during the epidemic, and potential relationships were analyzed.Results: Among 375 included patients, 329 were infected with coronavirus 2019. Compared with non-infected patients, infected ones were more likely to have higher disease activity (p = 0.006). However, Janus kinase (JAK) inhibitor use was lower in detected COVID-19 cases than in non-infected cases in our cohort. Disease symptoms during COVID-19 were more commonly present in the non-JAK group than JAK groups, including rhinorrhea (p = 0.030), nasal congestion (p = 0.023), sore throat (p = 0.042), pneumonia (p = 0.044), headache (p = 0.023), and prevalence of palpitation (p = 0.015). In this study, 29 participants underwent tonsillectomy. Tonsillectomized patients showed a significantly higher prevalence of pneumonia than patients who did not undergo tonsillectomy (p = 0.009). The associated effect factors were displayed in the case of previous tonsillectomy using multivariate analysis and Firth’s penalized likelihood. JAK inhibitor use (p = 0.025) and pneumonia (p = 0.011) were more likely to develop in patients with a history of tonsillectomy.Conclusion: Disease activity was inversely correlated with JAK inhibitor use in SAPHO patients with COVID-19 during the pandemic. Thus, JAK antagonists have protective effects on SAPHO patients with infections and can significantly mitigate new clinical crown symptoms. However, there was a significant negative correlation between tonsillectomy and the prevalence of SAPHO with COVID-19, which demonstrates that tonsillectomy may be associated with an increased risk of COVID-19 adverse outcomes, especially in cases of taste disorders and pneumonia.Keywords
This publication has 25 references indexed in Scilit:
- COVID-19 and the clinical course of rheumatic manifestationsClinical Rheumatology, 2021
- Rheumatic Disease-Related Symptoms during the Height of the COVID-19 PandemicHSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2020
- Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general populationThe Lancet Rheumatology, 2020
- Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, ChinaJAMA Network Open, 2020
- Coronavirus disease 2019 (COVID-19): a clinical updateFrontiers of Medicine, 2020
- Risk factors of post-tonsillectomy dysgeusiaAuris Nasus Larynx, 2020
- Taste disorders after tonsillectomy: A long‐term follow‐upThe Laryngoscope, 2012
- Taste disturbance following tonsillectomy–a prospective studyThe Laryngoscope, 2010
- Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single center study of a cohort of 71 subjectsArthritis Care & Research, 2009
- “SAPHO syndrome and infections”Autoimmunity Reviews, 2009